Vaccine stocks rose sharply in morning trading, with Vir technology rising over 15% and Novavax rising over 4%

Tiger Newspress2021-12-15

Vaccine stocks rose sharply in morning trading, with Vir technology rising over 15% and Novavax rising over 4%.Vir Biotechnology (VIR) unveiled late Tuesday new preclinical data that demonstrates the impact of the "significant antigenic shift" of the new SARS-CoV-2 Omicron variant on neutralizing activity of monoclonal antibodies.

The company said a "significant" reduction in plasma neutralizing activity was observed against omicron in sera from vaccinated and convalescent individuals.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

发表看法
27